€49.31
0.57%
Xetra, Sep 23, 05:37 pm CEST. Closed.
ISIN
DE000BAY0017
Symbol
BAYN

Bayer Target price 2026 - Analyst rating & recommendation

Bayer Classifications & Recommendation

Buy
83%
Hold
17%

Bayer Price Target

Target Price €59.67
Price €49.31
Potential 21.01%
Number of Estimates 24
24 Analysts have issued a price target Bayer 2027 . The average Bayer target price is €59.67. This is 21.01% higher than the current stock price. The highest price target is €73.50 49.06% , the lowest is €46.46 5.78% .
A rating was issued by 29 analysts: 24 Analysts recommend Bayer to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2027 of 21.01% . Most analysts recommend the Bayer stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Sep '25 Sep '26
Estimates
Revenue Billion € 9.66 10.12
3.09% 4.80%
EBITDA Margin 4.78% 14.93%
49.23% 212.17%
Net Margin -9.97% 4.72%
76.24% 147.35%

24 Analysts have issued a sales forecast Bayer 2026 . The average Bayer sales estimate is

€46.7b
unlock
. This is
2.85% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€48.9b 7.70%
unlock
, the lowest is
€44.1b 2.85%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 €45.6b 2.21%
2026
€46.7b 2.40%
unlock
2027
€48.0b 2.77%
unlock
2028
€49.5b 3.25%
unlock
2029
€50.0b 0.98%
unlock
2030
€50.6b 1.13%
unlock
2031
€53.2b 5.12%
unlock
2032
€53.9b 1.33%
unlock

22 Analysts have issued an Bayer EBITDA forecast 2026. The average Bayer EBITDA estimate is

€9.9b
unlock
. This is
111.47% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€11.8b 150.79%
unlock
, the lowest is
€8.1b 72.02%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 €8.7b 27.36%
2026
€9.9b 13.43%
unlock
2027
€10.6b 6.35%
unlock
2028
€11.3b 7.22%
unlock
2029
€11.5b 2.03%
unlock
2030
€11.5b 0.15%
unlock
2031
€11.4b 0.72%
unlock
2032
€11.5b 0.44%
unlock

EBITDA Margin

2025 19.19% 25.72%
2026
21.26% 10.77%
unlock
2027
22.00% 3.48%
unlock
2028
22.85% 3.86%
unlock
2029
23.09% 1.05%
unlock
2030
22.79% 1.30%
unlock

24 Bayer Analysts have issued a net profit forecast 2026. The average Bayer net profit estimate is

€4.5b
unlock
. This is
360.55% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€4.9b 381.45%
unlock
, the lowest is
€4.1b 334.88%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 €-3.6b 41.85%
2026
€4.5b 225.09%
unlock
2027
€4.8b 5.35%
unlock
2028
€5.4b 12.25%
unlock
2029
€5.5b 3.09%
unlock
2030
€5.2b 5.51%
unlock

Net Margin

2025 -7.94% 45.06%
2026
9.70% 222.12%
unlock
2027
9.95% 2.58%
unlock
2028
10.81% 8.64%
unlock
2029
11.04% 2.13%
unlock
2030
10.31% 6.61%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Sep '25 Sep '26
Estimates
Earnings Per Share -0.98 0.49
77.00% 150.00%

24 Analysts have issued a Bayer forecast for earnings per share. The average Bayer EPS is

€4.61
unlock
. This is
360.45% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
€4.98 381.36%
unlock
, the lowest is
€4.16 335.03%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 €-3.68 41.54%
2026
€4.61 225.27%
unlock
2027
€4.86 5.42%
unlock
2028
€5.45 12.14%
unlock
2029
€5.62 3.12%
unlock
2030
€5.31 5.52%
unlock
2031
€5.93 11.68%
unlock
2032
€6.09 2.70%
unlock

P/E ratio

Current -27.99 254.26%
2026
10.75 138.40%
unlock
2027
10.20 5.12%
unlock
2028
9.09 10.88%
unlock
2029
8.82 2.97%
unlock
2030
9.33 5.78%
unlock

Based on analysts' sales estimates for 2026, the Bayer stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.80 38.46%
2026
1.75 2.96%
unlock
2027
1.70 2.70%
unlock
2028
1.65 3.15%
unlock
2029
1.63 0.97%
unlock
2030
1.61 1.12%
unlock
2031
1.53 4.87%
unlock
2032
1.51 1.31%
unlock

P/S ratio

Current 1.06 81.10%
2026
1.03 2.78%
unlock
2027
1.00 2.69%
unlock
2028
0.97 3.15%
unlock
2029
0.96 0.97%
unlock
2030
0.95 1.12%
unlock
2031
0.91 4.87%
unlock
2032
0.89 1.31%
unlock

Current Bayer Upgrades & Downgrades

Analyst Rating Action Date
JEFFERIES
Hold
Hold
Unchanged Jul 13 2026
BERENBERG
Hold
Hold
Unchanged Jul 13 2026
DAY BY DAY
Sell
Buy
Upgrade Jul 12 2026
LANDESBANK BADEN-WUERTTEMBERG
Buy
Buy
Unchanged Jul 12 2026
ROTHSCHILD & CO REDBURN
Neutral
Buy
Upgrade Jul 08 2026
DZ BANK
Sell
Buy
Upgrade Jun 28 2026
MWB RESEARCH AG
Buy
Buy
Unchanged Jun 25 2026
Analyst Rating Date
Unchanged
JEFFERIES:
Hold
Hold
Jul 13 2026
Unchanged
BERENBERG:
Hold
Hold
Jul 13 2026
Upgrade
DAY BY DAY:
Sell
Buy
Jul 12 2026
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Buy
Buy
Jul 12 2026
Upgrade
ROTHSCHILD & CO REDBURN:
Neutral
Buy
Jul 08 2026
Upgrade
DZ BANK:
Sell
Buy
Jun 28 2026
Unchanged
MWB RESEARCH AG:
Buy
Buy
Jun 25 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today